What Researchers Did
Researchers conducted a systematic review of Chinese literature to investigate the clinical effectiveness of hyperbaric oxygen treatment for term neonates with hypoxic-ischaemic encephalopathy.
What They Found
They found 20 trials, predominantly from Chinese sources, which generally reported poor quality by Western standards. Treatment with hyperbaric oxygen showed better outcomes, with meta-analysis odds ratios of 0.26 (95% CI 0.14 to 0.46) for mortality and 0.41 (0.27 to 0.61) for neurological sequelae. This suggests HBO possibly reduces mortality and neurological sequelae.
What This Means for Canadian Patients
While hyperbaric oxygen treatment showed potential benefits in reducing mortality and neurological problems for neonates with hypoxic-ischaemic encephalopathy, the evidence quality is a significant concern. Canadian patients would need further high-quality, Western-standard research before this treatment could be widely considered.
Canadian Relevance
There is no direct Canadian connection to this study, as it focuses on Chinese literature and a treatment less commonly used in Western countries.
Study Limitations
The primary limitation of this systematic review is the poor reporting quality of almost all included trials, mainly from Chinese sources, by Western standards.